Galera to present at h.c. wainwright bioconnect conference

Malvern, pa., jan. 06, 2022 (globe newswire) -- galera therapeutics, inc. (nasdaq: grtx), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that mel sorensen, m.d., president and chief executive officer, will present at the h.c. wainwright bioconnect conference, taking place january 10-13, 2022.
GRTX Ratings Summary
GRTX Quant Ranking